Clinical Trial Update: Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss [Phase 1]

View source ↗

Summary

Phase 1 study of AG-270 in participants with MTAP-deleted advanced solid tumors or lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• AG-270 (AG-270)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Advanced Solid Tumors, Lymphoma | Phase 1 | Status: TERMINATED